STOCK TITAN

Nano-X Imaging Ltd. - $NNOX STOCK NEWS

Welcome to our dedicated page for Nano-X Imaging Ltd. news (Ticker: $NNOX), a resource for investors and traders seeking the latest updates and insights on Nano-X Imaging Ltd. stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nano-X Imaging Ltd.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nano-X Imaging Ltd.'s position in the market.

Rhea-AI Summary
Nanox's HealthFLD AI software receives FDA clearance for automated liver attenuation analysis from CT scans, aiding in the early detection of metabolic diseases like MASLD. The software demonstrated high performance in detecting hepatic steatosis in a study, expanding Nanox's AI solutions for population health.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.09%
Tags
-
Rhea-AI Summary
Nanox Imaging Ltd announced the passing of its founder and non-executive chairman, Ran Poliakine, due to a medical condition. Mr. Poliakine was a serial entrepreneur with over 35 years of experience, who founded more than 20 companies and held over 70 patents in various fields. After founding Nanox and taking it public in 2020, he moved to a non-executive role in 2021. The company's CEO, Erez Meltzer, expressed deep condolences and emphasized the goal of bringing Nanox imaging solutions into widespread use to honor Ran's legacy and vision.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.32%
Tags
none
-
Rhea-AI Summary
NANO-X IMAGING LTD (NNOX) announced its third quarter results for 2023, revealing a net loss of $21.4 million and $2.5 million in revenue. The company achieved significant milestones such as entering into a manufacture and supply agreement with Varex Imaging Corporation and establishing its first U.S.-based commercial site and demonstration center. The company also received regulatory approvals and started the process of securing the CE mark designation in the European Union.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.54%
Tags
Rhea-AI Summary
NANO-X IMAGING LTD (NASDAQ: NNOX) announced the release of its financial results for the quarter ended September 30, 2023 on November 28, 2023, and its upcoming Investor Day on December 4, 2023 in New York City. Interested parties can register for the conference call and access the live webcast through links provided on the Nanox website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.44%
Tags
conferences earnings
-
Rhea-AI Summary
NANO-X IMAGING postpones Investor Day due to recent events in Israel
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.96%
Tags
none
-
Rhea-AI Summary
NANO-X IMAGING LTD enters into a manufacture and supply agreement with Varex Imaging Corporation to supply X-ray tubes for the Nanox.ARC system. Nanox believes the digital cathode X-ray source can achieve the same functionalities as legacy X-ray cathodes at a lower cost. Nanox intends to add AI technology in the future. Varex will receive a revenue-sharing fee based on Nanox's pay-per-scan revenue. Nanox received FDA clearance to market the Nanox.ARC system. Nanox.ARC systems have been installed in Nigeria, Morocco, and Ghana for demonstration and training purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.94%
Tags
none
Rhea-AI Summary
NANO-X IMAGING LTD (NASDAQ: NNOX) to host Investor Day at Nasdaq on Oct. 17, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.74%
Tags
conferences
-
Rhea-AI Summary
Nanox.AI's HealthCCSng solution used in study finds 58% of patients had moderate to severe levels of coronary artery calcium (CAC), a predictor of future cardiac events.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.24%
Tags
AI
-
Rhea-AI Summary
Nanox to participate in Cantor Fitzgerald Global Healthcare Conference 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags
conferences
Rhea-AI Summary
Nanox reports Q2 2023 results with $2.6M revenue and $17.4M net loss. Received FDA clearance for Nanox.ARC system. Progress in securing chip and tube supplies. Raised $30M in direct offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.09%
Tags
Nano-X Imaging Ltd.

Nasdaq:NNOX

NNOX Rankings

NNOX Stock Data

483.11M
55.12M
9.13%
22.76%
15.35%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Neve Ilan

About NNOX

nanox is developing the next generation of x-ray emitters based on groundbreaking nanotechnology. nanox emitters will finally bring x-ray imaging into the digital era, enabling novel 3d imaging systems with unmatched performance